Stephen Douglas Barrett

USPTO Granted Patents = 45 (Patent Applications = 9)

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 14)

Average Co-Inventor Count = 5.6

ph-index = 13

Forward Citations = 555(Granted Patents)

Location History:

Ferndale, MI (US) (1994)
Livonia, MI (US) (1996 - 2006)
Hartland, MI (US) (2003 - 2024)

Company Filing History:

21 out of 2,538

Warner-lambert Company

patents

17 out of 29

Cayman Chemical Company Incorporated

Thesan Pharmaceuticals, Inc.

patents

6. 1 out of 66

Medicis Pharmaceutical Corporation

patents

7. 1 out of 7

Graceway Pharmaceuticals, LLC

patents

8. 1 out of 1

Fbm Therapeutics, LLC

patent

9. 1 out of 3,370

University of Michigan

patents

where one patent can have more than one assignee

Years Active: 1994-2024

Loading Chart...

45 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11884624 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2024-01-30),

2. 11345690 - Methods of synthesizing a difluorolactam analog (2022-05-31),

3. 11066361 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2021-07-20),

4. 10729810 - Methods, systems, and compositions for promoting bone growth (2020-08-04),

5. 10556862 - Difluorolactam compounds as EPreceptor-selective agonists for use in the treatment of EP-mediated diseases and conditions (2020-02-11),

6. 9938289 - Therapeutic pyrazolyl thienopyridines (2018-04-10),

7. 9914725 - Methods of synthesizing a difluorolactam analog (2018-03-13),

8. 9701630 - [object Object] (2017-07-11),

9. 9688627 - [object Object] (2017-06-27),

10. 9676712 - [object Object] (2017-06-13),

11. 9487478 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2016-11-08),

12. 9440919 - Difluorolactam compositions for EP4-mediated osteo related diseases and conditions (2016-09-13),

13. 9260450 - Therapeutic pyrazolyl thienopyridines (2016-02-16),

14. 9180116 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2015-11-10),

15. 9126973 - [object Object] (2015-09-08),

Title: The Innovative Journey of Stephen Douglas Barrett

Introduction:

Stephen Douglas Barrett, a talented inventor hailing from Hartland, MI, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents:

Barrett's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a solar-powered irrigation system designed to enhance agricultural practices sustainably.

Career Highlights:

With a career spanning over two decades, Barrett has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on various sectors, from healthcare to agriculture.

Collaborations:

Throughout his career, Barrett has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful commercialization of several groundbreaking technologies.

Conclusion:

In conclusion, Stephen Douglas Barrett's passion for innovation and commitment to creating a positive change in the world through his inventions make him a true pioneer in the field of technology. His relentless pursuit of excellence continues to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.